{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:53:23Z","timestamp":1781506403577,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Klinikum der Universit\u00e4t M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dementia affects over 50\u00a0million individuals globally, predominantly due to Alzheimer\u2019s disease (AD). Effective early detection and intervention remain clinical challenges, as there is a lack of unified, portable solutions to assess multiple biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We evaluated Evoked Potential Tomography (EPT), an EEG-based method using a novel visual evoked potential protocol. An automated pipeline for EEG preprocessing, ERP extraction, feature selection, optimization, and regression modeling was developed to estimate key AD biomarkers: PET-amyloid standardized uptake value ratio (SUVR), CSF phosphorylated tau (\n                      <jats:italic>p<\/jats:italic>\n                      -tau181), Free and Cued Selective Reminding Test (FCSRT), and Mini-Mental State Examination (MMSE) scores.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Regression models using ERP features from dementia participants demonstrated strong correlations (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.8\u20130.94,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01) between predicted and true PET-amyloid SUVR,\n                      <jats:italic>p<\/jats:italic>\n                      -tau181, FCSRT, and MMSE values. In an independent external cohort, PET-amyloid SUVR predictions remained significantly associated with true values (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.60,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Despite limitations, these preliminary results support EPT\u2019s potential as a sensitive and non-invasive method for estimating AD-related biomarkers in a clinically enriched AD cohort. Further validation studies are ongoing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-026-02076-7","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T05:04:51Z","timestamp":1781240691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Estimation of positron emission tomography amyloid load and related biomarkers in Alzheimer\u2019s disease using evoked potential tomography EEG: development and internal validation in a cross-sectional cohort"],"prefix":"10.1186","volume":"18","author":[{"given":"Boris-Stephan","family":"Rauchmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hamet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesyin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homeira","family":"Kafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Rexwinkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Brendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai","family":"Franzmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Pogarell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"H\u00f6glinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Perneczky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"2076_CR1","doi-asserted-by":"crossref","unstructured":"Palop JJ, Mucke L. Amyloid-\u0392-induced neuronal dysfunction in Alzheimer\u2019s disease: From synapses toward neural networks. Nat Neurosci. 2010;13(7):812\u20138. Available from: https:\/\/www.nature.com\/articles\/nn.2583","DOI":"10.1038\/nn.2583"},{"key":"2076_CR2","doi-asserted-by":"crossref","unstructured":"Mucke L, Selkoe DJ. Neurotoxicity of Amyloid \u03b2-Protein: Synaptic and Network Dysfunction. Cold Spring Harb Perspect Med. 2012;2(7):a006338. Available from: . http:\/\/perspectivesinmedicine.cshlp.org\/content\/2\/7\/a006338.full","DOI":"10.1101\/cshperspect.a006338"},{"key":"2076_CR3","doi-asserted-by":"publisher","unstructured":"Hector A, Brouillette J. Hyperactivity Induced by Soluble Amyloid-\u03b2 Oligomers in the Early Stages of Alzheimer\u2019s Disease. Front Mol Neurosci. 2021;13:600084. Available from: . https:\/\/doi.org\/10.3389\/fnmol.2020.600084","DOI":"10.3389\/fnmol.2020.600084"},{"key":"2076_CR4","doi-asserted-by":"crossref","unstructured":"Stargardt A, Swaab DF, Bossers K. The storm before the quiet: neuronal hyperactivity and A\u03b2 in the presymptomatic stages of Alzheimer\u2019s disease. Neurobiol Aging. 2015;36(1):1\u201311. Available from: \u00a0. https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0197458014005272","DOI":"10.1016\/j.neurobiolaging.2014.08.014"},{"key":"2076_CR5","doi-asserted-by":"crossref","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH. Phosphorylated Tau in Alzheimer\u2019s Disease and Other Tauopathies. International Journal of Molecular Sciences. 2022, Vol 23, Page 12841. 2022;23(21):12841. Available from: \u00a0. https:\/\/www.mdpi.com\/1422-0067\/23\/21\/12841\/htm","DOI":"10.3390\/ijms232112841"},{"key":"2076_CR6","doi-asserted-by":"crossref","unstructured":"John A, Reddy PH. Synaptic basis of Alzheimer\u2019s disease: Focus on synaptic amyloid beta, P-tau and mitochondria. Ageing Res Rev. 2021;65:101208. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1568163720303433","DOI":"10.1016\/j.arr.2020.101208"},{"key":"2076_CR7","doi-asserted-by":"crossref","unstructured":"Brown J, Camporesi E, Lantero-Rodriguez J, Olsson M, Wang A, Medem B et al. Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillations. Acta Neuropathologica Communications. 2023.;11(1):1\u201322. Available from: \u00a0 https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-023-01562-5","DOI":"10.1186\/s40478-023-01562-5"},{"key":"2076_CR8","doi-asserted-by":"crossref","unstructured":"Perinelli A, Assecondi S, Tagliabue CF, Mazza V. Power shift and connectivity changes in healthy aging during resting-state EEG. Neuroimage. 2022;256:119247. Available from: \u00a0 https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1053811922003718","DOI":"10.1016\/j.neuroimage.2022.119247"},{"key":"2076_CR9","doi-asserted-by":"crossref","unstructured":"Paitel ER, Otteman CBD, Polking MC, Licht HJ, Nielson KA. Functional and effective EEG connectivity patterns in Alzheimer\u2019s disease and mild cognitive impairment: a systematic review. Front Aging Neurosci. 2025;17:1496235. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11861106\/","DOI":"10.3389\/fnagi.2025.1496235"},{"key":"2076_CR10","doi-asserted-by":"publisher","unstructured":"Uyanik H, Sengur A, Salvi M, Tan RS, Tan JH, Acharya UR. Automated Detection of Neurological and Mental Health Disorders Using EEG Signals and Artificial Intelligence: A Systematic Review. Wiley Interdiscip Rev Data Min Knowl Discov. 2025;15(1):e70002. Available from: https:\/\/doi.org\/10.1002\/widm.70002","DOI":"10.1002\/widm.70002"},{"key":"2076_CR11","doi-asserted-by":"crossref","unstructured":"Gouw AA, Alsema AM, Tijms BM, Borta A, Scheltens P, Stam CJ et al. EEG spectral analysis as a putative early prognostic biomarker in nondemented, amyloid positive subjects. Neurobiol Aging. 2017;57:133\u201342. Available from: . https:\/\/pubmed.ncbi.nlm.nih.gov\/28646686\/","DOI":"10.1016\/j.neurobiolaging.2017.05.017"},{"key":"2076_CR12","doi-asserted-by":"crossref","unstructured":"Jones DT, Graff-Radford J, Lowe VJ, Wiste HJ, Gunter JL, Senjem ML et al. Tau, amyloid, and cascading network failure across the Alzheimer\u2019s disease spectrum. Cortex . 2017;97:143\u201359. Available from: \u00a0. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0010945217303246","DOI":"10.1016\/j.cortex.2017.09.018"},{"key":"2076_CR13","doi-asserted-by":"crossref","unstructured":"Aghakhanyan G, Rullmann M, Rumpf J, Schroeter ML, Scherlach C, Patt M et al. Interplay of tau and functional network connectivity in progressive supranuclear palsy: a [18F]PI-2620 PET\/MRI study. Eur J Nucl Med Mol Imaging. 2022;50(1):103\u201314. Available from: \u00a0. https:\/\/link.springer.com\/article\/10.1007\/s00259-022-05952-0","DOI":"10.1007\/s00259-022-05952-0"},{"key":"2076_CR14","doi-asserted-by":"crossref","unstructured":"\u015eeker M, \u00d6zbek Y, Yener G, \u00d6zerdem MS. Complexity of EEG Dynamics for Early Diagnosis of Alzheimer\u2019s Disease Using Permutation Entropy Neuromarker. Comput Methods Programs Biomed. 2021;206. Available from: \u00a0. https:\/\/pubmed.ncbi.nlm.nih.gov\/33957376\/","DOI":"10.1016\/j.cmpb.2021.106116"},{"key":"2076_CR15","doi-asserted-by":"crossref","unstructured":"Mirakhorli J, Amindavar H, Mirakhorli M. A new method to predict anomaly in brain network based on graph deep learning. Rev Neurosci. 2020;31(6):681\u20139. Available from: \u00a0. https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2019-0108\/html","DOI":"10.1515\/revneuro-2019-0108"},{"key":"2076_CR16","doi-asserted-by":"crossref","unstructured":"Shan X, Cao J, Huo S, Chen L, Sarrigiannis PG, Zhao Y. Spatial\u2013temporal graph convolutional network for Alzheimer classification based on brain functional connectivity imaging of electroencephalogram. Hum Brain Mapp. 2022;43(17):5194. Available from: \u00a0. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9812255\/","DOI":"10.1002\/hbm.25994"},{"key":"2076_CR17","doi-asserted-by":"publisher","unstructured":"Shim Y, Yang DW, Ho S, Hong YJ, Jeong JH, Park KH et al. Electroencephalography for Early Detection of Alzheimer\u2019s Disease in Subjective Cognitive Decline. Dement Neurocogn Disord. 2022;21(4):126\u201337. Available from: . https:\/\/doi.org\/10.12779\/dnd.2022.21.4.126","DOI":"10.12779\/dnd.2022.21.4.126"},{"key":"2076_CR18","doi-asserted-by":"crossref","unstructured":"Perez V, Duque A, Hidalgo V, Salvador A. EEG frequency bands in subjective cognitive decline: A systematic review of resting state studies. Biol Psychol. 2024;191:108823. Available from: \u00a0. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0301051124000826","DOI":"10.1016\/j.biopsycho.2024.108823"},{"key":"2076_CR19","doi-asserted-by":"publisher","unstructured":"Lemos R, Sim\u00f5es MR, Santiago B, Santana I. The free and cued selective reminding test: Validation for mild cognitive impairment and Alzheimer\u2019s disease. J Neuropsychol. 2015;9(2):242\u201357. Available from: \u00a0. https:\/\/doi.org\/10.1111\/jnp.12048","DOI":"10.1111\/jnp.12048"},{"key":"2076_CR20","doi-asserted-by":"crossref","unstructured":"Grober E, Sanders AE, Hall C, Lipton RB. Free and Cued Selective Reminding Identifies Very Mild Dementia in Primary Care. Alzheimer Dis Assoc Disord. 2010;24(3):284. Available from: \u00a0 https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2929322\/","DOI":"10.1097\/WAD.0b013e3181cfc78b"},{"key":"2076_CR21","doi-asserted-by":"crossref","unstructured":"Galea M, Woodward M. Mini-Mental State Examination (MMSE): Commentary. Aust J Physiother. 2005;51(3):198. Available from: \u00a0 https:\/\/pubmed.ncbi.nlm.nih.gov\/16187459\/","DOI":"10.1016\/S0004-9514(05)70034-9"},{"key":"2076_CR22","doi-asserted-by":"crossref","unstructured":"Dansson HV, Stempfle L, Egilsd\u00f3ttir H, Schliep A, Portelius E, Blennow K et al. Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer\u2019s disease. Alzheimers Res Ther. 2021;13(1):1\u201316. Available from: \u00a0 https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00886-5","DOI":"10.21203\/rs.3.rs-290530\/v1"},{"key":"2076_CR23","doi-asserted-by":"crossref","unstructured":"Javitt DC, Martinez A, Sehatpour P, Beloborodova A, Habeck C, Gazes Y et al. Disruption of early visual processing in amyloid-positive healthy individuals and mild cognitive impairment. Alzheimers Res Ther. 2023;15(1). Available from: \u00a0. https:\/\/pubmed.ncbi.nlm.nih.gov\/36855162\/","DOI":"10.1186\/s13195-023-01189-7"},{"key":"2076_CR24","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez A, Gaspar PA, Hillyard SA, Andersen SK, Lopez-Calderon J, Corcoran CM et al. Impaired motion processing in schizophrenia and the attenuated psychosis syndrome: Etiological and clinical implications. Am J Psychiatry. 2018;175(12):1243\u201354. Available from: \u00a0 https:\/\/pubmed.ncbi.nlm.nih.gov\/30278791\/","DOI":"10.1176\/appi.ajp.2018.18010072"},{"key":"2076_CR25","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez A, Tobe R, Dias EC, Ardekani BA, Veenstra-VanderWeele J, Patel G et al. Differential patterns of visual sensory alteration underlying face emotion recognition impairment and motion perception deficits in schizophrenia and autism spectrum disorders. Biol Psychiatry. 2019;86(7):557. Available from: \u00a0. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7197738\/","DOI":"10.1016\/j.biopsych.2019.05.016"},{"key":"2076_CR26","unstructured":"Olichney JM, Yang JC, Taylor J, Kutas M. Cognitive Event-Related Potentials: Biomarkers of Synaptic Dysfunction Across the Stages of Alzheimer\u2019s Disease. J Alzheimers Dis. 2011;26(0 3):215. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3765089\/"},{"key":"2076_CR27","doi-asserted-by":"crossref","unstructured":"Niraula S, Doderer JJ, Indulkar S, Berry KP, Hauser WL, L\u2019Esperance OJ et al. Excitation-inhibition imbalance disrupts visual familiarity in amyloid and non-pathology conditions. Cell Rep. 2023;42(1):111946. Available from: \u00a0 https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9939293\/","DOI":"10.1016\/j.celrep.2022.111946"},{"key":"2076_CR28","doi-asserted-by":"crossref","unstructured":"Orekhova EV, Stroganova TA, Schneiderman JF, Lundstr\u00f6m S, Riaz B, Sarovic D et al. Neural gain control measured through cortical gamma oscillations is associated with sensory sensitivity. Hum Brain Mapp. 2018;40(5):1583. Available from: \u00a0 https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6865508\/","DOI":"10.1002\/hbm.24469"},{"key":"2076_CR29","doi-asserted-by":"publisher","unstructured":"Valenti DA. Alzheimer\u2019s Disease: Screening Biomarkers Using Frequency Doubling Technology Visual Field. Int Sch Res Notices. 2013;2013(1):989583. Available from: https:\/\/doi.org\/10.1155\/2013\/989583","DOI":"10.1155\/2013\/989583"},{"key":"2076_CR30","doi-asserted-by":"crossref","unstructured":"Gilmore GC, Whitehouse PJ. Contrast sensitivity in Alzheimer\u2019s disease: a 1-year longitudinal analysis. Optom Vis Sci. 1995;72(2):83\u201391. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/7753532\/","DOI":"10.1097\/00006324-199502000-00007"},{"key":"2076_CR31","doi-asserted-by":"crossref","unstructured":"Chang LYL, Lowe J, Ardiles A, Lim J, Grey AC, Robertson K et al. Alzheimer\u2019s disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers. Alzheimers Dement. 2014;10(2):251\u201361. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24011928\/","DOI":"10.1016\/j.jalz.2013.06.004"},{"key":"2076_CR32","doi-asserted-by":"crossref","unstructured":"Rauchmann BS, Brendel M, Franzmeier N, Trappmann L, Zaganjori M, Ersoezlue E et al. Microglial Activation and Connectivity in Alzheimer Disease and Aging. Ann Neurol. 2022;92(5):768\u201381. Available from: \u00a0 https:\/\/pubmed.ncbi.nlm.nih.gov\/36053756\/","DOI":"10.1002\/ana.26465"},{"key":"2076_CR33","doi-asserted-by":"crossref","unstructured":"Fillenbaum GG, van Belle G, Morris JC, Mohs RC, Mirra SS, Davis PC et al. Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD): The first twenty years. Alzheimer\u2019s and Dementia. 2008;4(2):96\u2013109. Available from: \u00a0 https:\/\/pubmed.ncbi.nlm.nih.gov\/18631955\/","DOI":"10.1016\/j.jalz.2007.08.005"},{"key":"2076_CR34","doi-asserted-by":"crossref","unstructured":"Chandler MJ, Lacritz LH, Hynan LS, Barnard HD, Allen G, Deschner M et al. A total score for the CERAD neuropsychological battery. Neurology. 2005;65(1):102\u20136. Available from: \u00a0. https:\/\/pubmed.ncbi.nlm.nih.gov\/16009893\/","DOI":"10.1212\/01.wnl.0000167607.63000.38"},{"key":"2076_CR35","doi-asserted-by":"crossref","unstructured":"Teichmann M, Epelbaum S, Samri D, Levy Nogueira M, Michon A, Hampel H et al. Free and Cued Selective Reminding Test \u2013 accuracy for the differential diagnosis of Alzheimer\u2019s and neurodegenerative diseases: A large-scale biomarker-characterized monocenter cohort study (ClinAD). Alzheimers Dement. 2017;13(8):913\u201323. Available from: . https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1552526017300146","DOI":"10.1016\/j.jalz.2016.12.014"},{"key":"2076_CR36","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398. Available from: \u00a0. https:\/\/pubmed.ncbi.nlm.nih.gov\/1202204\/"},{"key":"2076_CR37","doi-asserted-by":"crossref","unstructured":"Arevalo-Rodriguez I, Smailagic N, Roqu\u00e9i Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A et al. Mini-Mental State Examination (MMSE) for the detection of Alzheimer\u2019s disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015;2015(3):CD010783. Available from: \u00a0. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6464748\/","DOI":"10.1002\/14651858.CD010783.pub2"},{"key":"2076_CR38","doi-asserted-by":"crossref","unstructured":"Dumurgier J, Schraen S, Gabelle A, Vercruysse O, Bombois S, Laplanche JL et al. Cerebrospinal fluid amyloid-\u03b2 42\/40 ratio in clinical setting of memory centers: A multicentric study. Alzheimers Res Ther. 2015;7(1). Available from: \u00a0 . https:\/\/pubmed.ncbi.nlm.nih.gov\/26034513\/","DOI":"10.1186\/s13195-015-0114-5"},{"issue":"1","key":"2076_CR39","doi-asserted-by":"publisher","first-page":"103682","DOI":"10.1016\/j.xpro.2025.103682","volume":"6","author":"G Ouyang","year":"2025","unstructured":"Ouyang G, Li Y. Protocol for semi-automatic EEG preprocessing incorporating independent component analysis and principal component analysis. STAR Protoc. 2025;6(1):103682.","journal-title":"STAR Protoc"},{"key":"2076_CR40","doi-asserted-by":"crossref","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB et al. A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016;87(5):539\u201347. Available from: \u00a0. https:\/\/pubmed.ncbi.nlm.nih.gov\/27371494\/","DOI":"10.1212\/WNL.0000000000002923"},{"key":"2076_CR41","doi-asserted-by":"crossref","unstructured":"Cavanagh JF, Wilson JK, Rieger RE, Gill D, Broadway JM, Story Remer JH et al. ERPs predict symptomatic distress and recovery in sub-acute mild traumatic brain injury. Neuropsychologia. 2019;132:107125. Available from: \u00a0. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6702033\/","DOI":"10.1016\/j.neuropsychologia.2019.107125"},{"key":"2076_CR42","doi-asserted-by":"crossref","unstructured":"Wisch JK, Gordon BA, Boerwinkle AH, Luckett PH, Bollinger JG, Ovod V et al. Predicting continuous amyloid PET values with CSF and plasma A\u03b242\/A\u03b240. Alzheimer\u2019s and Dementia: Diagnosis, Assessment and Disease Monitoring. 2023;15(1). Available from: \u00a0. https:\/\/pubmed.ncbi.nlm.nih.gov\/36874595\/","DOI":"10.1002\/dad2.12405"},{"key":"2076_CR43","doi-asserted-by":"crossref","unstructured":"De Meyer S, Schaeverbeke JM, Verberk IMW, Gille B, De Schaepdryver M, Luckett ES et al. Comparison of ELISA- and SIMOA-based quantification of plasma A\u03b2 ratios for early detection of cerebral amyloidosis. Alzheimers Res Ther. 2020;12(1). Available from: \u00a0. https:\/\/pubmed.ncbi.nlm.nih.gov\/33278904\/","DOI":"10.1186\/s13195-020-00728-w"},{"key":"2076_CR44","doi-asserted-by":"publisher","unstructured":"B\u00f6ken D, Xia Z, Lam JYL, Fertan E, Wu Y, English EA et al. Ultrasensitive Protein Aggregate Quantification Assays for Neurodegenerative Diseases on the Simoa Platform. Anal Chem. 2024;97(1):290\u20139. Available from: \u00a0[. https:\/\/doi.org\/10.1021\/acs.analchem.4c04188","DOI":"10.1021\/acs.analchem.4c04188"},{"key":"2076_CR45","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Grijalba V, Romero J, Pesini P, Sarasa L, Monle\u00f3n I, San-Jos\u00e9 I et al. Plasma A\u03b242\/40 Ratio Detects Early Stages of Alzheimer\u2019s Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study. J Prev Alzheimers Dis. 2019;6(1):34\u201341. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30569084\/.","DOI":"10.14283\/jpad.2018.41"},{"key":"2076_CR46","doi-asserted-by":"crossref","unstructured":"Weber DM, Taylor SW, Lagier RJ, Kim JC, Goldman SM, Clarke NJ et al. Clinical utility of plasma A\u03b242\/40 ratio by LC-MS\/MS in Alzheimer\u2019s disease assessment. Frontiers in Neurology. 2024;15:1364658. Available from: https:\/\/naccdata.org\/data-collection\/forms-documentation\/uds-3.","DOI":"10.3389\/fneur.2024.1364658"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02076-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02076-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02076-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:21:28Z","timestamp":1781504488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-02076-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2076"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-02076-7","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted following the Declaration of Helsinki. All participants provided written informed consent before inclusion. The protocol was approved by the ethics committee of LMU Munich (project numbers 17\u2013755 and 17\u2013569).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"All participants provided written consent for publication of de-identified study data. No personally identifiable information or images are included in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"R.P. has received honoraria for advisory boards and speaker engagements from Roche, EISAI, Eli Lilly, Biogen, Janssen-Cilag, AstraZeneca, Schwabe, Grifols, Novo Nordisk, and Tabuk. Vistim Labs, Inc. provided personnel for this research on EEG-based diagnostics for dementia. The results have potential commercial implications for Vistim Labs. M.B. is a member of the Neuroimaging Committee of the EANM. M.B. has received speaker honoraria from Roche, GE Healthcare, Iba, and Life Molecular Imaging; has advised Life Molecular Imaging and GE Healthcare; and is currently on the advisory board of MIAC. N.F. has received honoraria for consulting and speaker engagements from GE Healthcare, Life Molecular Imaging, EISAI, Biogen, and MSD.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}